Activated Nrf2 impairs liver regeneration in mice by activation of genes involved in cell-cycle control and apoptosis

Hepatology

Volumn 60, Issue 2, 2014, Pages 670-678

  Köhler, Ulrike A ^a   Kurinna, Svitlana ^a   Schwitter, Dominik ^a   Marti, Andrea ^a   Schäfer, Matthias ^a   Hellerbrand, Claus ^b   Speicher, Tobias ^a   Werner, Sabine ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2B; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE REGULATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE ACTIVATION; LIVER CELL; LIVER FIBROSIS; LIVER INJURY; LIVER REGENERATION; MOUSE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; UPREGULATION;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARBON TETRACHLORIDE POISONING; CELL CYCLE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P15; DISEASE MODELS, ANIMAL; DRUG-INDUCED LIVER INJURY; HEPATOCYTES; HOMEOSTASIS; INSULIN-LIKE GROWTH FACTOR I; LIVER CIRRHOSIS; LIVER REGENERATION; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; NF-E2-RELATED FACTOR 2; PROTO-ONCOGENE PROTEINS; RECEPTOR, NOTCH1;

EID: 84904764018     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26964     Document Type: Article

References (33)

1. Bonner MY, Arbiser JL. Targeting NADPH oxidases for the treatment of cancer and inflammation. Cell Mol Life Sci 2012;69:2435-2442.
2. D'Autréaux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 2007;8:813-824.
3. Sykiotis GP, Bohmann D. Stress-activated cap'n'collar transcription factors in aging and human disease. Sci Signal 2010;3:re3.
4. Kobayashi M, Yamamoto M. Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid Redox Signal 2005;7:385-394.
5. Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 2007;47:89-116.
6. Baird L, Dinkova-Kostova AT. The cytoprotective role of the Keap1-Nrf2 pathway. Arch Toxicol 2011:85:241-272.
7. Sporn MB, Liby KT. Nrf2 and cancer: the good, the bad and the importance of context. Nat Rev Cancer 2012;12:564-571.
8. Okawa H, Motohashi H, Kobayashi A, Aburatani H, Kensler TW, Yamamoto M. Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. Biochem Biophys Res Commun 2006;339:79-88.
9. Liu J, Wu KC, Lu Y-F, Ekuase E, Klaassen CD. Nrf2 protection against liver injury produced by various hepatotoxicants. Oxid Med Cell Longev 2013;2013:305861.
10. Klaassen CD, Reisman SA. Nrf2 the rescue: effects of the antioxidative/electrophilic response on the liver. Toxicol Appl Pharmacol 2010;244:57-65.
11. Michalopoulos GK. Liver regeneration. J Cell Physiol 2007;213:286-300.
12. Beyer TA, Xu W, Teupser D, auf dem Keller U, Bugnon P, Hildt E, et al. Impaired liver regeneration in Nrf2 knockout mice: role of ROS-mediated insulin/IGF-1 resistance. EMBO J 2008;27:212-223.
13. Böhm F, Speicher T, Hellerbrand C, Dickson C, Partanen JM, Ornitz DM, et al. FGF receptors 1 and 2 control chemically induced injury and compound detoxification in regenerating livers of mice. Gastroenterology 2010;139:1385-1396.
14. Schäfer M, Farwanah H, Willrodt A-H, Huebner AJ, Sandhoff K, Roop D, et al. Nrf2 links epidermal barrier function with antioxidant defense. EMBO Mol Med 2012;4:364-379.
15. Postic C, Magnuson MA. DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis 2000;26:149-150.
16. Weber LWD, Boll M, Stampfl A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 2003;33:105-136.
17. Wu J, Danielsson A, Zern MA. Toxicity of hepatotoxins: new insights into mechanisms and therapy. Exp Opin Invest Drugs 1999;8:585-607.
18. Wakabayashi N, Shin S, Slocum SL, Agoston ES, Wakabayashi J, Kwak MK, et al. Regulation of Notch1 signaling by Nrf2: implications for tissue regeneration. Sci Signal 2010;3:ra52.
19. Menthena A, Koehler CI, Sandhu JS, Yovchev MI, Hurston E, Shafritz DA, et al. Activin a, p15INK4b signaling, and cell competition promote stem/progenitor cell repopulation of livers in aging rats. Gastroenterology 2011;140:1009-1020.
20. Malhotra D, Portales-Casamar E, Singh A, Srivastava S, Arenillas D, Happel C, et al. Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis. Nucl Acids Res 2010;38:5718-5734.
21. Chorley BN, Campbell MR, Wang X, Karaca M, Sambandan D, Bangura F, et al. Identification of novel Nrf2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha. Nucl Acids Res 2012;40:7416-7429.
22. Xu W, Hellerbrand C, Köhler U, Bugnon P, Kan Y, Werner S, et al. The Nrf2 transcription factor protects from toxin-induced liver injury and fibrosis. Lab Invest 2008:88:1068-1078.
23. Schäfer M, Dütsch S, auf dem Keller U, Navid F, Schwarz A, Johnson DA, et al. Nrf2 establishes a glutathione-mediated gradient of UVB cytoprotection in the epidermis. Genes Dev 2010;24:1045-1058.
24. Tian H, Zhang B, Di J, Jiang G, Chen F, Li H, et al. Keap1: one stone kills three birds Nrf2, IKK and Bcl-2/Bcl-xL. Cancer Lett 2012;325:26-34.
25. Awad MM, Sanders JA, Gruppuso PA. A potential role for p15(Ink4b) and p57(Kip2) in liver development. FEBS Lett 2000;483:160-164.
26. Zarco N, Gonzalez-Ramirez R, Gonzalez RO, Segovia J. Gas1 induces cell death through an intrinsic apoptotic pathway. Apoptosis 2012;17:627-635.
27. Akiyama T, Tanaka S. Bim: guardian of tissue homeostasis and critical regulator of the immune system, tumorigenesis and bone biology. Arch Immunol Ther Exp 2011;59:277-287.
28. Kodama T, Hikita H, Kawaguchi T, Saito Y, Tanaka S, Shigekawa M, et al. The Bcl-2 homology 3 (BH3)-only proteins Bim and Bid are functionally active and restrained by anti-apoptotic B-cell CLL/lymphoma 2 (Bcl-2) family proteins in healthy liver. J Biol Chem 2013;288:30009-30018.
29. Niture SK, Jaiswal AK. Nrf2-induced anti-apoptotic Bcl-xl protein enhances cell survival and drug resistance. Free Radic Biol Med 2012;57:119-131.
30. Niture SK, Jaiswal AK. Nrf2 up-regulates anti-apoptotic protein Bcl-2 and prevents cellular apoptosis. J Biol Chem 2012;287:9873-9878.
31. Corlu A, Loyer P. Regulation of the G1/S transition in hepatocytes: involvement of the cyclin-dependent kinase Cdk1 in the DNA replication. Int J Hepatol 2012;2012:689324.
32. Mitsuishi Y, Taguchi K, Kawatani Y, Shibata T, Nukiwa T, Aburatani H, et al. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 2012;22:66-79.
33. Rushmore TH, Morton MR, Pickett CB. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem 1991;266:11632-11639.